RecruitingNCT03049254
Mayo AVC Registry and Biobank
Studying Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mayo Clinic
- Principal Investigator
- Virend Somers, PhD, MDMayo Clinic
- Enrollment
- 1000 enrolled
- Eligibility
- All sexes
- Timeline
- 2018 – 2026
Study locations (2)
- Mayo Clinic, Rochester, Minnesota, United States
- Royal Papworth Hospital NHS Foundation Trust, Papworth Everard, Cambridge, United Kingdom
Collaborators
Cambridge University Hospitals NHS Foundation Trust
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03049254 on ClinicalTrials.govOther trials for Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT03593317Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVDHospices Civils de Lyon
- RECRUITINGPHASE1NCT06228924Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVCTenaya Therapeutics
- RECRUITINGNANCT05209776Local Inflammation in Arrhythmogenic Right Ventricular CardiomyopathyUniversity Hospital, Toulouse
See all trials for Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant →